MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

A Cedars-Sinai study helps explain why half of diabetes patients experience deterioration of the cornea, the transparent dome ...

MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions.

AI can make ophthalmology more accessible, accurate, and preventative by using smart optical technology and data-driven diagnostics.

The alliance extends a deal streak in genetic medicine for Lilly and hands the company rights to an experimental treatment ...

Please provide your email address to receive an email when new articles are posted on . Neuropathy and inflammation work together to drive common manifestations of corneal disease. Early intervention ...

Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

Coffee is the fuel of many people's morning commutes, workouts, and late-night work sessions, but a new study suggests that ...

Virtual reality (VR) gaming has gained significant attention in recent years, with an increasing number of users integrating ...

Dry eye treatments include over-the-counter eye drops and prescription medicines. The AMCP abstract included immunomodulators ...